To our Sanguine Community,
With the ongoing COVID-19 pandemic, it has been a difficult time for us all. Like many other companies, Sanguine has made difficult decisions and considered what our role is during this time. We realized that as innovators and leaders in medical research, we have an obligation to help our global community. This is why Sanguine has partnered with researchers to develop a treatment for COVID-19, and we are hopeful that this research will save thousands that are suffering. If you or anyone you know has recovered from COVID-19, please sign up to be contacted by one of our study coordinators.
We understand that many of you may have concerns about our mobile health staff coming into your home; that is why we have implemented stringent precautions and equipped our team with additional personal protective equipment for at-home appointments. According to the WIRB-Copernicus IRB and the Food and Drug Administration (FDA), at-home research is the safest, most convenient way to navigate the current circumstances.
We continue to monitor the spread of COVID-19 via the Center of Disease Control (CDC) and the World Health Organization (WHO) to protect our research participants. We are rescheduling appointments when necessary, but as long as researchers are in the lab, Sanguine will continue at-home research with appropriate precautions in place because on the other side of this, we think that you deserve medical advancements and the chance at better treatment.
Together, we will get through this. Together, we will make a difference.
The Sanguine Team